Fushuang Zheng
No.36 Sanhao Road
Shenyang, 110004, China
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Recent advances in engineered nanozymes for precision lung cancer therapy.
Journal: Materials today. Bio
Published: April 17, 2026
Correction: Dual-responsive nanoparticles targeting ACE-II senescence for therapeutic mitigation of acute lung injury.
Journal: Journal of nanobiotechnology
Published: December 20, 2025
ADAR-mediated RNA editing in CNS disorders: from pathogenic mechanisms to therapeutic opportunities.
ADAR-mediated RNA editing in CNS disorders: from pathogenic mechanisms to therapeutic opportunities.
Journal: Cellular & molecular biology letters
Published: November 27, 2025
Exposure to environmental xenobiotics and lung tissue function: A comprehensive review on biological mechanisms and pathways.
Journal: Ecotoxicology and environmental safety
Published: October 02, 2025
Design of conditional and tumor-activated PROTACs for selective degradation in lung cancer.
Journal: European journal of medicinal chemistry
Published: September 28, 2025
Ginsenoside Rb1-enhanced decellularized extracellular matrix hydrogels ameliorates mitochondrial dysfunction and cellular aging in sepsis-induced acute lung injury.
Journal: Journal of ginseng research
Published: February 04, 2025
Advancements in liquid biopsy for breast Cancer: Molecular biomarkers and clinical applications.
Journal: Cancer treatment reviews
Published: January 26, 2025
Dual-responsive nanoparticles targeting ACE-II senescence for therapeutic mitigation of acute lung injury.
Journal: Journal of nanobiotechnology
Published: December 05, 2024
Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages.
Journal: Redox report : communications in free radical research
Published: July 08, 2022
Sevoflurane suppresses NLRP3 inflammasome-mediated pyroptotic cell death to attenuate lipopolysaccharide-induced acute lung injury through inducing GSK-3β phosphorylation and activation.
Journal: International immunopharmacology
Published: March 07, 2022
Activation of the AMPK-ULK1 pathway mediated protective autophagy by sevoflurane anesthesia restrains LPS-induced acute lung injury (ALI).
Journal: International immunopharmacology
Published: February 15, 2022
Sevoflurane anesthesia ameliorates LPS-induced acute lung injury (ALI) by modulating a novel LncRNA LINC00839/miR-223/NLRP3 axis.
Journal: BMC pulmonary medicine
Published: January 14, 2022
Last Updated: 09/26/2026